| Models Name |
Cat.No. |
Animal Type |
Disease Area |
|
Metabolic syndrome, Calorie restriction-induced, in mouse (C57BL/6J)
|
AB69605 |
mouse |
Metabolic syndrome |
|
Metabolic syndrome, high-fat diet-induced, in mouse (C57BL/6J)
|
AB69606 |
mouse |
Metabolic syndrome |
|
Metabolic syndrome, high-fat diet/olanzapine-induced, in mouse (C57BL/6J)
|
AB69607 |
mouse |
Metabolic syndrome |
|
Metabolic syndrome, high-fat/high-sucrose diet-induced, in mouse (C57BL/6J)
|
AB69608 |
mouse |
Metabolic syndrome |
|
Metabolic syndrome, olanzapine-induced, in rmouse (C57BL/6J)
|
AB69609 |
mouse |
Metabolic syndrome |
|
Metastasis-Suppressor KiSS-1 inhibition, in mouse (C57BL/6J)
|
AB69610 |
mouse |
|
|
Metastatic cancer (to liver), xenograft (B16F10), in mouse (C57BL/6J)
|
AB69612 |
mouse |
Cancer,metastatic (to liver) |
|
Metastatic cancer (to liver), xenograft (CMT93), in mouse (C57BL/6J)
|
AB69613 |
mouse |
Cancer,metastatic (to liver) |
|
Metastatic cancer (to liver), xenograft (EO771), in mouse (C57BL/6J)
|
AB69614 |
mouse |
Cancer,metastatic (to liver) |
|
Metastatic cancer (to liver), xenograft (KPC), in mouse (C57BL/6J)
|
AB69615 |
mouse |
Cancer,metastatic (to liver) |